Dermatica

The quietly radical part of the operation isn't the dermatologists on staff; it's the pharmacy behind them. Rather than stocking finished tubes, the company runs a compounding facility that mixes each customer's medicine to order, blending the chosen actives into a proprietary hydrating vehicle it calls SmartBase, a cream carrying hyaluronic acid, ceramides, glycerin, and panthenol. A single tube can therefore stack several drugs at once, a combination a patient could never buy off a shelf because no manufacturer sells it as one product.

The customer journey is deliberately frictionless: a questionnaire, a few clear phone photos of your face, and a remote assessment that produces a formula mailed to your door. There is no waiting room and no fixed catalog to choose from, which is the whole point. When the brand crossed into the United States it landed squarely against Curology, the San Francisco company that had already popularized photo-based custom prescriptions stateside, and the two have been read as transatlantic mirrors of the same idea ever since.

What keeps the model honest is the feedback loop. Because strength and ingredients are adjusted by a real prescriber rather than fixed at purchase, a formula can be dialed down when skin flares or pushed up once tolerance builds, the kind of titration that mimics how a clinic actually escalates a retinoid. That iterative tuning, not any single molecule, is the genuine innovation.

The limitations are structural. A questionnaire and photographs capture a lot, but they cannot palpate a lesion, biopsy a suspicious mole, or read the subtleties a trained eye catches in person. Compounded prescribing also concentrates a great deal of trust in a process the patient never physically attends. For straightforward acne, pigmentation, and early aging, supervised remotely and pursued with patience, it is a sound, low-friction route; for anything diagnostically uncertain, an examination room still wins.

Sources:[1][2][3]